Your browser doesn't support javascript.
loading
HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials.
Richman, Susan D; Southward, Katie; Chambers, Philip; Cross, Debra; Barrett, Jennifer; Hemmings, Gemma; Taylor, Morag; Wood, Henry; Hutchins, Gordon; Foster, Joseph M; Oumie, Assa; Spink, Karen G; Brown, Sarah R; Jones, Marc; Kerr, David; Handley, Kelly; Gray, Richard; Seymour, Matthew; Quirke, Philip.
Afiliación
  • Richman SD; Section of Pathology and Tumour Biology, Leeds Institute of Cancer and Pathology, University of Leeds, UK.
  • Southward K; Section of Pathology and Tumour Biology, Leeds Institute of Cancer and Pathology, University of Leeds, UK.
  • Chambers P; Section of Pathology and Tumour Biology, Leeds Institute of Cancer and Pathology, University of Leeds, UK.
  • Cross D; Histopathology and Molecular Pathology, St James University Hospital, Leeds, UK.
  • Barrett J; Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, UK.
  • Hemmings G; Section of Pathology and Tumour Biology, Leeds Institute of Cancer and Pathology, University of Leeds, UK.
  • Taylor M; Section of Pathology and Tumour Biology, Leeds Institute of Cancer and Pathology, University of Leeds, UK.
  • Wood H; Section of Pathology and Tumour Biology, Leeds Institute of Cancer and Pathology, University of Leeds, UK.
  • Hutchins G; Section of Pathology and Tumour Biology, Leeds Institute of Cancer and Pathology, University of Leeds, UK.
  • Foster JM; Affymetrix UK Ltd, High Wycombe, UK.
  • Oumie A; Affymetrix UK Ltd, High Wycombe, UK.
  • Spink KG; Affymetrix UK Ltd, High Wycombe, UK.
  • Brown SR; Clinical Trials Research Unit, University of Leeds, Leeds, UK.
  • Jones M; Clinical Trials Research Unit, University of Leeds, Leeds, UK.
  • Kerr D; Cancer Medicine, University of Oxford, UK.
  • Handley K; Birmingham Clinical Trials Unit, University of Birmingham, UK.
  • Gray R; Clinical Trials Service Unit and Epidemiology Studies Unit, University of Oxford, UK.
  • Seymour M; Section of Oncology, Leeds Institute of Cancer and Pathology, University of Leeds, UK.
  • Quirke P; Section of Pathology and Tumour Biology, Leeds Institute of Cancer and Pathology, University of Leeds, UK.
J Pathol ; 238(4): 562-70, 2016 Mar.
Article en En | MEDLINE | ID: mdl-26690310
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Regulación Neoplásica de la Expresión Génica / Receptor ErbB-2 / Variaciones en el Número de Copia de ADN / Mutación / Recurrencia Local de Neoplasia Límite: Female / Humans / Male Idioma: En Revista: J Pathol Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Regulación Neoplásica de la Expresión Génica / Receptor ErbB-2 / Variaciones en el Número de Copia de ADN / Mutación / Recurrencia Local de Neoplasia Límite: Female / Humans / Male Idioma: En Revista: J Pathol Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido